Stifel Financial
TPTX

Stifel Financial’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Stifel Financial’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,690
Closed -$644K – 3509
2021
Q3 		$644K Sell
9,690
-208
-2% -$14.8K ﹤0.01% 2432
2021
Q2 		$773K Buy
+9,898
New +$731K ﹤0.01% 2286
2021
Q1 		– Sell
-5,878
Closed -$716K – 3321
2020
Q4 		$716K Buy
+5,878
New +$644K ﹤0.01% 2086

Other funds holding TPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Stifel Financial's TPTX Position: Q4 2021 in Review

Stifel Financial sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q4 2021, closing a stake of 9,690 shares — an estimated $644K sold.

Stifel Financial first reported a position in TPTX in Q4 2020 and held it in 3 quarters. The position peaked at $773K in Q2 2021. 172 funds tracked by Wall St. Rank hold TPTX as of Q4 2021.

  • Stifel Financial reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Stifel Financial sold 9,690 Turning Point Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $644K.
  • Stifel Financial first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Stifel Financial's Turning Point Therapeutics, Inc. Common Stock position peaked at $773K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Stifel Financial's 13F filing for Q4 2021, filed 14 Feb 2022.